Streetbeat News

Analyst Ratings

PFE

A significant investor has taken a bearish stance on Pfizer (NYSE:PFE), with 53% of recent trades being bearish and 46% bullish. The total amount for put options was $1,310,868 and for call options $253,745. Whales have been targeting a price range from $25.0 to $40.0 for Pfizer over the last 3 months. Pfizer's current price is $36.04, down 0.77%. Several financial institutions have downgraded their actions on Pfizer, with price targets ranging from $40 to $75.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

AXSM

Over the past 3 months, 11 analysts have published their opinion on Axsome Therapeutics (NASDAQ:AXSM) stock. The company has an average price target of $115.45 with a high of $200.00 and a low of $87.00. The average price target has increased by 6.11% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

PTLO

Over the past 3 months, 4 analysts have published their opinion on Portillos (NASDAQ:PTLO) stock, with an average price target of $25.5 versus the current price of $22.85. The average price target has increased by 4.81% over the past month. The analysts are generally bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

BG

Four analysts have provided ratings for Bunge (NYSE:BG) in the last quarter, with one bullish, two somewhat bullish, and one indifferent. The average price target is $121.0, compared to Bunge's current price of $101.44, implying an upside. The average price target has increased by 5.22% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

WRB

WR Berkley (NYSE:WRB) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The company has an average 12-month price target of $78.25, representing a 1.57% decrease from the previous average price target of $79.50.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

ROKU

Roku (NASDAQ:ROKU) has received mixed analyst ratings in the last quarter, with 5 bullish, 4 somewhat bullish, 6 indifferent, and 1 bearish. The average price target is $72.0, which is lower than the current price of $76.3075. The average price target has increased by 5.57% from the previous average of $68.20.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

TS

Over the past 3 months, 5 analysts have published their opinion on Tenaris (NYSE:TS) stock. The company has an average price target of $41.96, representing a 3.92% decrease from the previous average price target of $43.67. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

MLTX

HC Wainwright has doubled the price target for MoonLake Immunotherapeutics (NASDAQ:MLTX) from $37 to $75 with a Buy rating, following positive results from its Phase 2 MIRA trial. The trial evaluated the Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS). The analyst raised the probability of approval for sonelokimab in HS and PsA to 70% and reduced the discount rate to 11% from 13%. MoonLake is also reportedly considering a potential sale.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:39 pm

JANX

Janux Therapeutics Inc (NASDAQ:JANX) announced positive interim Phase 1 clinical data for its prostate cancer candidate, PSMA-TRACTr JANX007. The drug has been well tolerated with no dose-limiting toxicities and showed clinical activity. Concurrently, Janux priced an underwritten offering of over 4 million shares and pre-funded warrants, expecting to raise approximately $60 million. William Blair notes that Janux shares are currently undervalued based on the potential of the company’s TRACTr platform.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:36 pm

DIS

EXPE

IAC

NFLX

Barry Diller, chairman of IAC Inc and Expedia Group Inc, suggests that both executives and top-paid actors should take a 25% pay cut to narrow the pay gap in the movie industry. The Writers Guild of America and SAG-AFTRA are on strike, which could have devastating effects on the movie industry if not resolved by September 1. Wedbush analyst Alicia Reese believes the strikes could impact Netflix's Q3, while other studios with struggling streaming platforms could be hit harder. Disney CEO Bob Iger is concerned about the unrealistic expectations of the strikers.

Portfolio Pulse from Anthony Noto

July 17, 2023 | 6:33 pm